News: Law Enforcement Updates
Case overview, USA v Capsulcn International Co Ltd et al
In May 2025, the U.S. District Court in the Western District of Texas unsealed an indictment against a CapsulCN International and three Chinese nationals for their alleged role in the illegal importation of pill-making equipment.
Indictment, USA v CapsulCN International Co Ltd et al
April 23, 2025
May 12, 2025: FDA will expand unannounced foreign facility inspections, it says
The FDA wants to ensure that domestic and foreign companies receive the same level of regulatory oversight.
Catch up on research PSM released about medicines imported from unregistered sources.
Prescription Drug Freight Fraud Report, March 2025
What if your blood thinners were made in an unverified location in Colombia? In March 2025, dozens of pharmaceutical shipments entered the U.S. that were manufactured in places no one would expect.
Pharmaceutical Border Security
Pharmaceutical border security Every day, inspectors from Customs and Border Protection, the Food and Drug Administration, and the Drug Enforcement Administration intercept scary medical products entering the U.S. This work is incredibly important to protect the safety of American patients and it's difficult because criminals never stop innovating. PSM supports the work of border inspectors…
Case overview, Gilead Sciences v Heal the World et al
Gilead Sciences has filed a civil complaint against a Queens, New York-based pharmacy that allegedly sold counterfeit HIV medicine.
Oregon State Pharmacy Association submits testimony to Oregon’s PDAB
Oregon State Pharmacy Association submits testimony to Oregon's PDAB On May 6, the Oregon State Pharmacy Association (OSPA) submitted testimony for the Oregon Prescription Drug Affordability Board's May 2025 meeting, suggesting that the board eliminate PBM spread pricing to improve prescription drug affordability. Read it here. Read the PDF. Learn more about: Upper payment limits…
Prescription Drug Affordability Board Activity, April 17 – April 30, 2025
Prescription Drug Affordability Board Activity, April 17 - April 30, 2025 Activities Summary Colorado: Colorado's PDAB updated the Colorado Prescription Drug Affordability Advisory Council on its progress on April 24, 2025. Conversation focused on gathering stakeholder feedback. Maryland: Maryland's Prescription Drug Affordability Advisory Council met on April 28,2025 to hear an expert presentation about Drug…
May 4, 2025: New study suggests more adverse events associated with compounded GLP-1s than standard formulations
New research shows a correlation between compounded weight loss and diabetes injectables and increased adverse events. GIlead Sciences is suing another New York City pharmacy that allegedly sold counterfeit HIV medicine.
ALERT: New FDA Warning Letter to www.thesafepills.org
The FDA has issued a warning to the operators of the online pharmacy www.thesafepills.org for illegally selling unapproved and misbranded opioid medications, including tapentadol products marketed as Aspadol and Typendol. These unauthorized drugs, sold without a prescription, pose significant health risks such as overdose, addiction, and even death.
